Clinical Trial Registration Policy

Clinical Trial Registration Policy

Aksara Health
Journal of Equity and Innovation in Resource-Limited Settings
 

Aksara Health supports prospective registration of clinical trials to promote transparency and reduce selective reporting.

1. Registration Requirement

Prospective clinical trials should be registered in an appropriate publicly accessible trial registry at or before the time of first participant consent for enrollment.

2. Registry Information

The manuscript should report the registry name and registration number. Registrations should contain meaningful and sufficiently complete protocol information.

3. Protocol and Outcome Consistency

Authors must disclose important differences between registered outcomes, the study protocol, and the submitted manuscript and explain changes transparently.

4. Late Registration

Retrospective registration is not considered equivalent to prospective registration. Exceptionally, editors may consider a late-registered study when a transparent and persuasive explanation is provided; acceptance is not guaranteed.

Last updated: September 2026